|
Harvey Gollman
Harvey Gollman, President of The Gollman Group Inc., has
been involved in the field of Nuclear Medicine since 1966. He has
had the opportunity to experience the full range of exciting developments
in the field of Nuclear Medicine including work with the first
commercial Positron Gamma Camera in 1968. He established his company
over 23 years ago to provide both equipment and consulting services
to the Nuclear Medicine marketplace. In 1990, he expanded to include
global involvement in the development of Radiochemistry Laboratories
for Medical Cyclotron Facilities.
In 2000, he added the PET consulting division to provide complete
turn-key PET imaging capability for private oncology practices
to create their own in-house scanner sites. Through these consulting
services, private oncology practices have been able to enhance
patient care with timely scheduling with the added benefit of the
participating in the financial returns from PET imaging.
|

|
|
Ron Waddel
Ron Waddle has been directly involved in all aspects of
Medical Imaging for over 30 years. His experience includes positions
as Chief Nuclear Medicine Technologist at Methodist Hospital in
Memphis, Radiology Manager at Memorial Hospital of Southern Oklahoma
at Ardmore, Oklahoma. Prior to joining The Gollman group in 1997,
he was Director of Nuclear Medical Imaging for Memorial Hospital
System in Houston for over 20 years and served as the Imaging Administrative
Director for Memorial Hospital Southwest. Ron has extensive technical
expertise in all aspects of Medical Imaging and extensive hands-on
experience in building and expanding nuclear cardiology and PET
imaging facilities, and serves an important role in our development
of Turn-Key Operations. |

|
|
Larry Windedahl
Larry began as a computer programmer in nuclear reactor research
for space applications, which led to his professional life in
nuclear instrumentation. His career includes a variety of sales
and marketing positions with Nuclear Chicago, Searle Radiographics,
and ADAC Laboratories, in medical imaging and oncology areas.
He has served in consulting rolls involving physics, neutron and
therapy accelerators, CT-based 3D, IMRT and ultrasound-based brachytherapy
implant planning, and both cyclotron and generator-based radiopharmaceutical
production. His depth and range of expertise can provide excellent
consultation for the highly successful implementation of Positron
Emission Tomography - including proforma economic analyses, site
selection, design, construction, and marketing of PET facilities,
hot labs, radio chemistry and radiopharmacy facilities.
Larry is a longstanding member of AAPM and SNM, and has presented
papers at local and national AAPM, SNM, and ICP meetings on subjects
including new radiopharmaceuticals, PET animal research, PET cardiology,
and breakeven analyses of clinical PET centers.
|

|